期刊文献+

猪与人致敏的淋巴细胞混合培养及其细胞因子检测 被引量:3

Pig and human sensitized lymphocyte co-culture and cytokines measurement
暂未订购
导出
摘要 目的 :探讨临床应用异种无细胞真皮基质 (Xeno ADM)的免疫反应机理。方法 :分离正常猪、正常人和接受Xeno -ADM复合移植的临床大面积烧伤患者的外周血单个核细胞 (PBMC) ,以前两种细胞为刺激细胞、后者为反应细胞 ,通过异种混合淋巴细胞培养 (Xeno -MLC)和同种异体混合淋巴细胞培养 (Allo -MLC)、3 H TdR掺入和酶联免疫吸附分析 (ELISA)方法 ,检测不同抗原对反应细胞增殖的刺激作用及其IL - 2 (IU·ml-1)、IL - 4 (IU·ml-1)和IFN - (ng·L-1)的动态变化。结果 :Xeno MLC组淋巴细胞增殖反应和培养 4d后的IL - 2、IL - 4、IFN - 的分泌水平均明显高于Allo -MLC组和空白对照组 (P <0 .0 5~ 0 .0 1)。结论 :有辅助性T淋巴细胞 - 1(Th1)和Th2参与的细胞免疫和IL - 4诱导的体液免疫可能是异种移植物 (Xeno -ADM)免疫排异反应的特征 ;用预先致敏的淋巴细胞进行MLC 。 Objective:To investigate the immune response mechanism involved in clinical transplantion of xenogeneic acellular dermal matrix(Xeno-ADM).Methods:Peripheric blood mononuclear cells(PBMC)were separated respectively from normal pigs and humans,and patients suffered extensive burn accepted the transplantation of Xeno-ADM.Then the mixed lymphocyte cultrue(MLC)was performed through co culturing PBMC of the patients with PBMC of the normal pigs or humans.The cells proliferation,and secretion of IL-2(IU·ml -1 ),IL-4(IU·ml -1 )and IFN-(ng·L -1 )were measured by 3 H-TdR incorporation and enzyme linked immunosorbent assay(ELISA).Results:At 4 days after culture,the cells proliferation and secretion of IL-2,IL-4,IFN  were significantly higher in MLC of normal pigs and patients than in that of normal humans and patients( P <0.05~0.01).Conclusion:Th1 and Th2-mediated immunity and IL-4 induced humoral immunity might be the characteristic of immunologic rejection to Xeno-ADM.MLC with sensitized lymphocyte may reflect the in vivo immunoreactivity more accurately.
出处 《西北国防医学杂志》 CAS 2002年第2期90-93,共4页 Medical Journal of National Defending Forces in Northwest China
基金 国家自然科学基金项目 (3 90 70 82 2 )
关键词 烧伤 无细胞真皮基质 异种移植 混合淋巴细胞培养 细胞因子 免疫学 Burn Acellular dermal matrix Xenotransplantation Mixed lymphocyte culture(MLC) Cytokine Immunology
  • 相关文献

参考文献2

二级参考文献6

共引文献30

同被引文献27

  • 1[1]Takami Y,Matsuda T,Yoshitake M,et al.Dispase/detergent treated dermal matrix as a dermal substitute.Burns 1996;22(3):182-90
  • 2[2]DeSagun EZ,Botts JL,Srivastava A,et al.Long-term outcome of xenogenic dermal matrix implantation in immunocompetent rats.J Surg Res 2001;96(1):96-106
  • 3[7]Munster AM,Smith-Meek M,Shalom A.Acellular allograft dermal matrix:immediate or delayed epidermal coverage? Burns 2001;27(2):150-3
  • 4[8]Sclafani AP,Romo T 3rd,Jacono AA,et al.Evaluation of acellular dermal graft(AlloDerm)sheet for soft tissue augmentation:a 1-year follow-up of clinical observations and histological findings.Arch Facial Plast Surg 2001;3(2):101-3
  • 5[9]Abenavoli FM,Corelli R.About AlloDerm.Plast Reconstr Surg 2001;108(7):2175-6
  • 6[11]Wang HJ,Chen TM,Cheng TY.Use of a porcine dermis template to enhance widely expanded mesh autologouse split-thickness skin graft growth:Preliminary report.J Trauma 1997;42(2):177-82
  • 7Srivastava A,Jennings LJ,Hanumadass M,et al.Xenogeneic acellular dermal matrix as a dermal substitate in rats.J Burn Care Rehabie,1999,20:382-390.
  • 8DeSagun EZ,Botts JL,Srivastava A,et al.Long-term outcome of xenogenic dermal matrix implantation in immunocompetent rats.J Surg Res,2001,96:96-106.
  • 9Gemmell E,Seymour GJ.Cytokines and T cell switching.Crit Rev Oral Biol Med,1994,5:249-279.
  • 10Walter RJ,Matsuda T,Reyes HM,et al.Characterization of acellular dermal matrices (ADMs)prepared by two different methods.Burns,1998,24:104-113.

引证文献3

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部